THE ROBERT AND MARGARET MOSS CHARITABLE TRUST
The Trust's objects are: (a) to foster and promote medical and scientific research into the vast problems of human nutrition, (b) to foster and promote medical research generally, (c) the relief of poverty and (d) the advancement of education.
Financial health, per its FY2026 accounts
The accounts state that unrestricted funds increased to £2,536,888, driven by investment revaluation gains. The trustees maintain reserves to generate investment income for grants and administration, considering the current level sufficient for future needs. The trust is prepared on a going concern basis with no material uncertainties identified.
What the accounts disclose
“The Trust’s income is entirely from investment dividends” — page 4
“The Trustees’ policy is to maintain sufficient income reserves to produce investment income of approximately £30,000 - £50,000 in each year”
“Remuneration and expenses were paid to Blake Morgan LLP of £7,384 (2025: £7,560), where JPO Cole is a consultant, for the administration of the Trust. Such payment is authorised under specific powers contained in the Trust deed.” — page 16
Trustees
- JOHN PETER OSWALD COLE
- Joanna Rachel Walliker
- MAGGIE PERRIN
- Sophie Elizabeth Durand
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 05/04/2026 | £39k | £52k |
| 05/04/2025 | £39k | £57k |
| 05/04/2024 | £34k | £49k |
| 05/04/2023 | £32k | £45k |
| 05/04/2022 | £30k | £55k |
Common questions
Is THE ROBERT AND MARGARET MOSS CHARITABLE TRUST financially healthy?
Per its FY2026 accounts: The accounts state that unrestricted funds increased to £2,536,888, driven by investment revaluation gains. The trustees maintain reserves to generate investment income for grants and administration, considering the current level sufficient for future needs. The trust is prepared on a going concern basis with no material uncertainties identified. Its FY2026 accounts were independently examined.